Homology medicines announces proposed public offering of common stock

In addition, Blueprint Medicines expects to grant the underwriters a 30-day option to purchase up to an additional $48,750,000 in shares of its common stock in connection with the public offering

Homology Medicines Announces Pricing of Public Offering of Common Stock today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public Homology Medicines Announces Proposed Public Offering of Common Stock $125.0 million of its common stock in an underwritten public offering. Homology expects to grant the underwriters a 30-day Homology expects to grant the underwriters a 30-day option to purchase up to an additional $18.75 million of its common stock. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares in the proposed offering are to be sold by Homology. Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of $22.50 per share, before underwriting discounts and commissions. Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced that it intends to offer and sell, subject to market and other conditions, $125.0 million of its common stock

7 Jan 2020 today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock. All of the shares are being 

Homology Medicines Announces Pricing of Public Offering of Common Stock today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public BEDFORD, Mass., April 9, 2019 - Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of $22.50 per share, before underwriting discounts and commissions.Homology also granted the underwriters a 30-day option to purchase up to an additional 833,333 Homology Medicines, Inc. (FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of Homology Medicines, Inc. (FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of Homology Medicines Announces Pricing of Public Offering of Common Stock today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public

Homology Medicines Announces Pricing of Public Offering of Common Stock today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public

Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced that it intends to offer and sell, subject to market and other conditions, $125.0 million of its common stock Homology Medicines Announces Pricing of Initial Public Offering announced today the pricing of its initial public offering of 9,000,000 shares of common stock at a public offering price of $16

Homology Medicines, Inc. (FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of

Homology Medicines, Inc. (FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of Homology Medicines, Inc. (FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of Homology Medicines Announces Pricing of Public Offering of Common Stock today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public Homology Medicines Announces Proposed Public Offering of Common Stock $125.0 million of its common stock in an underwritten public offering. Homology expects to grant the underwriters a 30-day Homology expects to grant the underwriters a 30-day option to purchase up to an additional $18.75 million of its common stock. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares in the proposed offering are to be sold by Homology. Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of $22.50 per share, before underwriting discounts and commissions.

Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced that it intends to offer and sell, subject to market and other conditions, $125.0 million of its common stock

BEDFORD, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. ( FIXX), a genetic medicines company, today announced that it intends to offer and sell, subject to market and other conditions, $125.0 million of its common stock in an underwritten public offering. Homology Medicines Announces Pricing of Public Offering of Common Stock today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public BEDFORD, Mass., April 9, 2019 - Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of $22.50 per share, before underwriting discounts and commissions.Homology also granted the underwriters a 30-day option to purchase up to an additional 833,333 Homology Medicines, Inc. (FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of Homology Medicines, Inc. (FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of

BEDFORD, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. ( FIXX), a genetic medicines company, today announced that it intends to offer and sell, subject to market and other conditions, $125.0 million of its common stock in an underwritten public offering. Homology Medicines Announces Pricing of Public Offering of Common Stock today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public BEDFORD, Mass., April 9, 2019 - Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, at a public offering price of $22.50 per share, before underwriting discounts and commissions.Homology also granted the underwriters a 30-day option to purchase up to an additional 833,333